KAM
Krensavage Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
+4,000
| New | +$2.1M | 1.11% | 15 |
|
|
2024
Q4 | – | Sell |
-353
| Closed | -$371K | – | 13 |
|
|
2024
Q3 | $371K | Sell |
353
-7,500
| -96% | -$7.88M | 0.21% | 12 |
|
|
2024
Q2 | $8.25M | Sell |
7,853
-4,641
| -37% | -$4.88M | 3.79% | 9 |
|
|
2024
Q1 | $12M | Sell |
12,494
-34,762
| -74% | -$33.5M | 5.33% | 8 |
|
|
2023
Q4 | $41.5M | Hold |
47,256
| – | – | 14.73% | 4 |
|
|
2023
Q3 | $38.9M | Sell |
47,256
-11,932
| -20% | -$9.82M | 14.32% | 4 |
|
|
2023
Q2 | $42.5M | Sell |
59,188
-300
| -0.5% | -$216K | 13.47% | 3 |
|
|
2023
Q1 | $48.9M | Sell |
59,488
-615
| -1% | -$505K | 14.84% | 2 |
|
|
2022
Q4 | $43.4M | Sell |
60,103
-786
| -1% | -$567K | 13.4% | 3 |
|
|
2022
Q3 | $41.9M | Buy |
60,889
+505
| +0.8% | +$348K | 13.36% | 3 |
|
|
2022
Q2 | $35.7M | Sell |
60,384
-6,496
| -10% | -$3.84M | 11.8% | 3 |
|
|
2022
Q1 | $46.7M | Sell |
66,880
-2,200
| -3% | -$1.54M | 16.1% | 1 |
|
|
2021
Q4 | $43.6M | Sell |
69,080
-4,063
| -6% | -$2.57M | 15.13% | 2 |
|
|
2021
Q3 | $44.3M | Sell |
73,143
-8,961
| -11% | -$5.42M | 13.89% | 3 |
|
|
2021
Q2 | $45.9M | Sell |
82,104
-594
| -0.7% | -$332K | 15.57% | 1 |
|
|
2021
Q1 | $39.1M | Buy |
82,698
+498
| +0.6% | +$236K | 13.54% | 4 |
|
|
2020
Q4 | $39.7M | Sell |
82,200
-58
| -0.1% | -$28K | 11.6% | 4 |
|
|
2020
Q3 | $46M | Buy |
82,258
+2,567
| +3% | +$1.44M | 14.66% | 1 |
|
|
2020
Q2 | $49.7M | Sell |
79,691
-7,126
| -8% | -$4.44M | 13.52% | 3 |
|
|
2020
Q1 | $42.4M | Sell |
86,817
-17,603
| -17% | -$8.6M | 13.64% | 2 |
|
|
2019
Q4 | $39.2M | Buy |
+104,420
| New | +$39.2M | 13.38% | 2 |
|